John A. Roush - 12 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
12 Dec 2025
Net transactions value
$0
Form type
4
Filing time
15 Dec 2025, 18:07:29 UTC
Previous filing
11 Dec 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roush John A Director C/O LEMAITRE VASCULAR, 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 15 Dec 2025 0001308225

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +5 +0.14% $0.000000 3,460 12 Dec 2025 Direct F1
transaction LMAT Common Stock Options Exercise $0 +5 +0.14% $0.000000 3,465 12 Dec 2025 Direct F1
holding LMAT Common Stock 181 12 Dec 2025 Indirect through spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -5 -100% $0.000000 0 12 Dec 2025 Common Stock 5 Direct F2, F3
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -5 -100% $0.000000 0 12 Dec 2025 Common Stock 5 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.
F4 These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.